Invion Limited
ASX: IVX.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Thian Chew
- Employees
- 8
- Headquarters
- Melbourne, Australia
- IPO year
- 2010
- Market cap
- A$5.6M
- Website
- https://www.inviongroup.com
Loading IVX…
Loading profile data…Frequently asked questions about IVX
What does Invion Limited (IVX.AX) do?
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and dev...
Where does IVX.AX trade?
Invion Limited (IVX.AX) trades on the Australian Securities Exchange.
What sector is IVX.AX in?
Invion Limited (IVX.AX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Invion Limited?
Thian Chew is the chief executive officer of Invion Limited (IVX.AX).
Where is Invion Limited headquartered?
Invion Limited is headquartered in Australia.
Does IVX.AX pay a dividend?
Invion Limited (IVX.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVX.AX go public?
Invion Limited (IVX.AX) completed its initial public offering in 2010.